A HETEROZYGOUS MUTATION (THE CODON FOR SER447-]A STOP CODON) IN LIPOPROTEIN-LIPASE CONTRIBUTES TO A DEFECT IN LIPID INTERFACE RECOGNITION IN A CASE WITH TYPE-I HYPERLIPIDEMIA

被引:66
作者
KOBAYASHI, J
NISHIDA, T
AMEIS, D
STAHNKE, G
SCHOTZ, MC
HASHIMOTO, H
FUKAMACHI, I
SAITO, KSY
YOSHIDA, S
机构
[1] OTSUKA CELLULAR TECHNOL INST,TOKUSHIMA,JAPAN
[2] UNIV HAMBURG,KRANKENHAUS EPPENDORF,MED KLIN,W-2000 HAMBURG 20,GERMANY
[3] UNIV CALIF LOS ANGELES,DEPT MED,LOS ANGELES,CA 90024
[4] SHIBAYAGI LAB BIOIMMUNOL SCI,SHIBUKAWA,GUMMA,JAPAN
[5] VET ADM MED CTR BRENTWOOD,LIPID RES,LOS ANGELES,CA 90073
关键词
D O I
10.1016/S0006-291X(05)80113-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Previously, we reported a case with type I hyperlipidemia due to a lipid interface recognition deficiency in lipoprotein lipase (LPL) (1). The LPL from postheparin plasma of this patient did not hydrolyze TritonX-100-triolein or very low density lipoprotein-triolein but did hydrolyze tributyrin and LysoPC-triolein substrates Sequence analysis of the proband's DNA revealed a heterozygous nucleotide change: a C→G transversion at position of 1595, resulting in changing the codon for Ser447 to a stop codon. Expression studies of this mutant LPLcDNA in Cos-1 cells produced and secreted considerable amounts of LPL mass in the culture media. The mutated LPL hydrolyzed much less TritonX-100-triolein than wild type LPL, whereas hydrolysis of tributyrin and LysoPC-triolein was the same with both the mutant and wild type LPL. These results suggest that this mutation might be responsible for the property of the LPL with a defect in lipid interface recognition in the type I patient we reported. © 1992 Academic Press, Inc.
引用
收藏
页码:70 / 77
页数:8
相关论文
共 24 条
[1]   FAMILIAL CHYLOMICRONEMIA (TYPE-I HYPERLIPOPROTEINEMIA) DUE TO A SINGLE MISSENSE MUTATION IN THE LIPOPROTEIN-LIPASE GENE [J].
AMEIS, D ;
KOBAYASHI, J ;
DAVIS, RC ;
BENZEEV, O ;
MALLOY, MJ ;
KANE, JP ;
LEE, G ;
WONG, H ;
HAVEL, RJ ;
SCHOTZ, MC .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 87 (04) :1165-1170
[2]  
BABIRAK SP, 1989, ARTERIOSCLEROSIS, V9, P5333
[3]   LIPOPROTEIN-LIPASE BETHESDA - A SINGLE AMINO-ACID SUBSTITUTION (ALA-176-]THR) LEADS TO ABNORMAL HEPARIN BINDING AND LOSS OF ENZYMATIC-ACTIVITY [J].
BEG, OU ;
MENG, MS ;
SKARLATOS, SI ;
PREVIATO, L ;
BRUNZELL, JD ;
BREWER, HB ;
FOJO, SS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (09) :3474-3478
[4]   LIPOPROTEIN-LIPASE - MODIFICATION OF ITS KINETIC-PROPERTIES BY MILD TRYPTIC DIGESTION [J].
BENGTSSON, G ;
OLIVECRONA, T .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1981, 113 (03) :547-554
[5]  
DEVLIN RH, 1990, AM J HUM GENET, V46, P112
[6]  
EMI M, 1990, J BIOL CHEM, V265, P5910
[7]  
EMI M, 1990, AM J HUM GENET, V47, P107
[8]  
FAUSTINELLA F, 1991, J BIOL CHEM, V266, P14418
[9]   AN ENZYME-LINKED IMMUNOASSAY FOR LIPOPROTEIN-LIPASE [J].
GOERS, JWF ;
PEDERSEN, ME ;
KERN, PA ;
ONG, J ;
SCHOTZ, MC .
ANALYTICAL BIOCHEMISTRY, 1987, 166 (01) :27-35
[10]   A HEPATIC LIPASE GENE MUTATION ASSOCIATED WITH HERITABLE LIPOLYTIC DEFICIENCY [J].
HEGELE, RA ;
VEZINA, C ;
MOORJANI, S ;
LUPIEN, PJ ;
GAGNE, C ;
BRUN, LD ;
LITTLE, JA ;
CONNELLY, PW .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1991, 72 (03) :730-732